Rapport Therapeutics, Inc. (RAPP)
35.21
-0.63
(-1.76%)
USD |
NASDAQ |
Jun 10, 16:00
35.24
+0.02
(+0.07%)
After-Hours: 20:00
Rapport Therapeutics Total Return Price : 35.21 for June 10, 2026
Total Return Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Return Price Data
| Date | Value |
|---|---|
| June 10, 2026 | 35.21 |
| June 09, 2026 | 35.84 |
| June 08, 2026 | 36.68 |
| June 05, 2026 | 36.10 |
| June 04, 2026 | 37.49 |
| June 03, 2026 | 37.00 |
| June 02, 2026 | 34.90 |
| June 01, 2026 | 37.11 |
| May 29, 2026 | 39.50 |
| May 28, 2026 | 39.49 |
| May 27, 2026 | 39.51 |
| May 26, 2026 | 39.71 |
| May 22, 2026 | 37.72 |
| May 21, 2026 | 36.70 |
| May 20, 2026 | 35.72 |
| May 19, 2026 | 34.37 |
| May 18, 2026 | 35.18 |
| May 15, 2026 | 37.07 |
| May 14, 2026 | 37.95 |
| May 13, 2026 | 38.08 |
| May 12, 2026 | 37.24 |
| May 11, 2026 | 38.43 |
| May 08, 2026 | 38.04 |
| May 07, 2026 | 39.93 |
| May 06, 2026 | 37.06 |
| Date | Value |
|---|---|
| May 05, 2026 | 35.59 |
| May 04, 2026 | 35.53 |
| May 01, 2026 | 33.89 |
| April 30, 2026 | 33.13 |
| April 29, 2026 | 33.00 |
| April 28, 2026 | 33.74 |
| April 27, 2026 | 35.40 |
| April 24, 2026 | 36.56 |
| April 23, 2026 | 36.36 |
| April 22, 2026 | 36.78 |
| April 21, 2026 | 36.95 |
| April 20, 2026 | 37.14 |
| April 17, 2026 | 39.71 |
| April 16, 2026 | 39.54 |
| April 15, 2026 | 36.71 |
| April 14, 2026 | 36.15 |
| April 13, 2026 | 34.65 |
| April 10, 2026 | 34.17 |
| April 09, 2026 | 34.22 |
| April 08, 2026 | 33.69 |
| April 07, 2026 | 33.49 |
| April 06, 2026 | 32.38 |
| April 02, 2026 | 33.58 |
| April 01, 2026 | 31.67 |
| March 31, 2026 | 31.29 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Price Benchmarks
| EyePoint, Inc. | 12.33 |
| Biofrontera, Inc. | 0.863 |
| ANI Pharmaceuticals, Inc. | 81.85 |
| Corcept Therapeutics, Inc. | 78.12 |
| Assertio Holdings, Inc. | 23.48 |